CPRX (Catalyst Corp) Bozor qiymatining balans qiymatiga nisbati

Catalyst Pharma (CPRX) kompaniyasining rasmiy ramzlari

Catalyst Pharmaceuticals (CPRX) kelajakdagi daromadlarni ta'minlash uchun birlashish kelishuvlari orqali noyob nevrologik dori vositalari portfelini kengaytirmoqda. Biznes o'zining asosiy mahsulotini sotishning eksklyuziv huquqiga tayanadi, bu esa yuqori daromadlilikni ta'minlaydi. Ushbu narxlar grafigi aktivning dinamikasini aks ettiradi, bunda ko'rsatkich 3.84 darajasida turibdi. Ishlab chiqarish quvvatlari uzilishlarsiz ishlamoqda va yangilangan logistika dori vositalarining bemorlarga o'z vaqtida yetkazib berilishini kafolatlaydi.

CPRX - catalystpharma.com Bozor qiymatining balans qiymatiga koeffitsiyenti 04.07.2022 - 25.07.2026 oraligʻida

Catalyst Pharma (CPRX) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Catalyst Pharmaceuticals|CPRX - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Catalyst Pharmaceuticals Inc|CPRX - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Catalyst Pharmaceuticals|CPRX - Kompaniyaning xususiy kapitali|Kapitallashuvning sof aktivlarga nisbati catalystpharma.com|CPRX - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Catalyst Pharmaceuticals|CPRX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Catalyst Pharmaceuticals Inc|CPRX - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Catalyst Pharmaceuticals Inc
Kompaniyaning dastlabki tahlili:Catalyst Pharmaceuticals, CPRX
Catalyst Pharmaceuticals Inc original mahsuloti

Ushbu koeffitsiyent sof kapitaldan yuqori bo'lgan bozor qiymati mukofotini belgilaydi va investorlarning kelajakdagi daromadlar bo'yicha kutganlarini anglatadi. Joriy bozor kapitalizatsiyasining kitob qiymatiga nisbatan tendentsiyasi Catalyst Pharmaceuticals (CPRX) avtomatlashtirilgan moddalar sintezi muvaffaqiyatiga bozorning joriy kayfiyatini real vaqt rejimida baholash imkonini beradi, chunki biofarmatsevtika aktivlarining qiymati ko'pincha murakkab klinik sinovlardan o'tayotgan dori vositalarining salohiyatini aks ettira olmaydi.

Raqobatchilar tahlili

Kapitallashuvning sof aktivlarga nisbati Biogen Inc.|NBIX (neurocrine.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Denali Therapeutics Inc. (DNLI)|HRMY: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati BHVN|Amylyx Corp (AMLX) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati TRVI|Kapitallashuvning sof aktivlarga nisbati praxismedicines.com|Bozor kapitallashuvining balans qiymatiga nisbati AVXL|Bozor kapitallashuvining balans qiymatiga nisbati CeriBell Inc CBLL|Kapitallashuvning sof aktivlarga nisbati prothena.com (PRTA)|Bozor kapitallashuvining balans qiymatiga multiplikatori Alector Inc. ALEC|Annexon, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|OMER: Bozor kapitallashuvining balans qiymatiga nisbati|Neurogene (NGNE) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati AC Immune S.A.|Kapitallashuvning sof aktivlarga nisbati VYGR (Voyager Pharma)|Bozor qiymatining balans qiymatiga koeffitsiyenti NMRA|SCLX (Scilex Holding Company) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi tevogen.com TVGN|Kapitallashuvning sof aktivlarga nisbati Alpha Cognition Inc. (ACOG)|CGTX - Bozor kapitallashuvining balans qiymatiga multiplikatori|Kapitallashuvning sof aktivlarga nisbati Inhibikase (IKT)|SAVA: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati assertiotx.com (ASRT)|Coya Therapeutics (COYA) - Sof aktivlarga nisbatan bozor kapitallashuvi|VTGN - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Ovid Rx|Bozor kapitallashuvining balans qiymatiga nisbati ABOS|Bozor kapitallashuvining balans qiymatiga nisbati CRVO (CervoMed Corporation)|Bozor qiymatining balans qiymatiga nisbati Alterity Therapeutics Limited|Clene Inc - Balans qiymatiga nisbatan bozor qiymati|PEPG: Bozor qiymatining balans qiymatiga nisbati|JUNS - Kapitallashuvning sof aktivlarga nisbati|RLMD: Bozor kapitallashuvining balans qiymatiga nisbati|Annovis Bio Corporation (ANVS) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GRCE|Kapitallashuvning sof aktivlarga nisbati fireflyneuro.com|Klotho Neurosciences Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti neurosense-tx.com NRSN|Kapitallashuvning sof aktivlarga nisbati RVPH (Reviva Pharmaceuticals Holdings)|MTVA - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati NeurAxis, Inc. NRXS|HSDT - Bozor kapitallashuvining balans qiymatiga multiplikatori|passagebio.com - Bozor kapitallashuvining balans qiymatiga nisbati|Neuphoria Therapeutics (NEUP) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati NERV|Kapitallashuvning sof aktivlarga nisbati Athira Pharma Corp|Bozor kapitallashuvining balans qiymatiga nisbati ADXN|Bozor kapitallashuvining balans qiymatiga nisbati ALZN (alzamend.com)|Bozor qiymatining balans qiymatiga nisbati Cyclerion Therapeutics, Inc. CYCN|Protagenic Therapeutics Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati KTTA (Pasithea)|CRGT - Balans qiymatiga nisbatan bozor kapitallashuvi|ATXI (Avenue Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|BCLI (brainstorm-cell.com) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Cara Therapeutics CARA|Sof aktivlarga nisbatan bozor kapitallashuvi CHRO|Eliem Therapeutics (ELYM) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati intracellulartherapies.com ITCI|LBPH - Kapitallashuvning sof aktivlarga nisbati|marinuspharma.com - Kapitallashuvning balans qiymatiga nisbati|NKGen Biotech (NKGN) - Bozor qiymatining balans qiymatiga nisbati|NRBO - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SAGE|Bozor qiymatining balans qiymatiga koeffitsiyenti Synaptogenix, Inc|TRVN (Trevena, Inc.) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VIGL|Anew Medical, Inc. (WENA) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CERE (Cerevel Therapeutics Inc)